Ceruloplasmin, Vitamin C, and Uric Acid Levels in Patients With Myocardial Infarction: A Comparative Cross-Sectional Study

被引:2
作者
Warjukar, Prajakta R. [1 ]
Paunipagar, Rina P. [1 ]
Timalsina, Dilip R. [1 ]
V. Mohabey, Ankush [1 ]
Jain, Pradeep B. [2 ]
Panbude, Swati P. [3 ]
机构
[1] Datta Meghe Inst Higher Educ & Res, Datta Meghe Med Coll, Biochem, Nagpur, India
[2] All India Inst Med Sci, Orthoped, Nagpur, India
[3] Datta Meghe Inst Higher Educ & Res, Jawaharlal Nehru Med Coll, Biochem, Wardha, India
关键词
oxidative stress; uric acid; vitamin c; ceruloplasmin; myocardial infarction; CORONARY-HEART-DISEASE; CARDIOVASCULAR-DISEASE; ARTERY-DISEASE; RISK-FACTORS; ANTIOXIDANTS;
D O I
10.7759/cureus.56122
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Global mortality is significantly influenced by myocardial infarction. Scientists have examined the role of the copper-containing protein ceruloplasmin in heart attacks. It helps to regulate oxidative stress, iron metabolism, and inflammation. Vitamin C's antioxidative qualities lend credence to the idea that it could help prevent cardiovascular disease. Several studies have shown that elevated uric acid levels are related to a higher risk of myocardial infarction. With this background, we conducted this study to estimate levels of ceruloplasmin, vitamin C, and uric acid in patients with myocardial infarction. Materials and methods: A tertiary care hospital in central India carried out this comparative cross-sectional study. The study was conducted between December 2022 and April 2023. Patients of any gender with newly diagnosed myocardial infarction who received admission to the intensive care unit and had ST-segment elevation of at least 2 mm in two or more consecutive electrocardiogram leads were included in the patient group. The control group consisted of individuals who did not exhibit any changes associated with myocardial infarction. Based on sex, age, and body mass index, the 75 control and 75 patients were matched. Ceruloplasmin, vitamin C, and uric acid were analyzed and compared. Results: The uric acid levels among the patient group were 10.34 +/- 3.23 mg/dL, and among the controls, they were 3.45 +/- 1.12 mg/dL (p<0.001). The ceruloplasmin levels among the patient group were 64.34 +/- 4.21 mg/dL, and among the controls, they were 29.23 +/- 3.82 mg/dL (p<0.001). The vitamin C levels among the patient group were 13.80 +/- 0.94 mu mol/L, and among the controls, they were 45.62 +/- 4.34 mu mol/L (p<0.001). Conclusion: The patients with myocardial infarction demonstrated significantly elevated levels of ceruloplasmin and uric acid, while their vitamin C levels were lower in comparison. It is crucial to comprehend the underlying mechanisms through which these parameters influence the development of myocardial infarction.
引用
收藏
页数:7
相关论文
共 26 条
[1]   Ceruloplasmin and Coronary Heart Disease-A Systematic Review [J].
Arenas de Larriva, Antonio P. ;
Limia-Perez, Laura ;
Alcala-Diaz, Juan F. ;
Alonso, Alvaro ;
Lopez-Miranda, Jose ;
Delgado-Lista, Javier .
NUTRIENTS, 2020, 12 (10) :1-15
[2]  
Bagheri Babak, 2015, Niger Med J, V56, P39, DOI [10.4103/0300-1652.149169, 10.4103/0300-1652.149169]
[3]   Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial [J].
Boaz, M ;
Smetana, S ;
Weinstein, T ;
Matas, Z ;
Gafter, U ;
Iaina, A ;
Knecht, A ;
Weissgarten, Y ;
Brunner, D ;
Fainaru, M ;
Green, MS .
LANCET, 2000, 356 (9237) :1213-1218
[4]   Serum uric acid and fatal myocardial infarction: detection of prognostic cut-off values: The URRAH (Uric Acid Right for Heart Health) study [J].
Casiglia, Edoardo ;
Tikhonoff, Valerie ;
Virdis, Agostino ;
Masi, Stefano ;
Barbagallo, Carlo M. ;
Bombelli, Michele ;
Bruno, Bernardino ;
Cicero, Arrigo F. G. ;
Cirillo, Massimo ;
Cirillo, Pietro ;
Desideri, Giovambattista ;
D'Elia, Lanfranco ;
Ferri, Claudio ;
Galletti, Ferruccio ;
Gesualdo, Loreto ;
Giannattasio, Cristina ;
Iaccarino, Guido ;
Lippa, Luciano ;
Mallamaci, Francesca ;
Maloberti, Alessandro ;
Mazza, Alberto ;
Muiesan, Maria Lorenza ;
Nazzaro, Pietro ;
Palatini, Paolo ;
Parati, Gianfranco ;
Pontremoli, Roberto ;
Quarti-Trevano, Fosca ;
Rattazzi, Marcello ;
Rivasi, Giulia ;
Salvetti, Massimo ;
Tocci, Giuliano ;
Ungar, Andrea ;
Verdecchia, Paolo ;
Viazzi, Francesca ;
Volpe, Massimo ;
Grassi, Guido ;
Borghi, Claudio .
JOURNAL OF HYPERTENSION, 2020, 38 (03) :412-419
[5]   Serum uric acid and risk for cardiovascular disease and death: The Framingham Heart Study [J].
Culleton, BF ;
Larson, MG ;
Kannel, WB ;
Levy, D .
ANNALS OF INTERNAL MEDICINE, 1999, 131 (01) :7-+
[6]   Long-term vitamin C treatment increases vascular tetrahydrobiopterin levels and nitric oxide synthase activity [J].
d'Uscio, LV ;
Milstien, S ;
Richardson, D ;
Smith, L ;
Katusic, ZS .
CIRCULATION RESEARCH, 2003, 92 (01) :88-95
[7]   Perspectives on the management of coronary artery disease in India [J].
Karthikeyan, Ganesan ;
Xavier, Denis ;
Prabhakaran, Doriaraj ;
Pais, Prem .
HEART, 2007, 93 (11) :1334-1338
[8]   Hyperuricemia and Coronary Heart Disease: A Systematic Review and Meta-Analysis [J].
Kim, Seo Young ;
Guevara, James P. ;
Kim, Kyoung Mi ;
Choi, Hyon K. ;
Heitjan, Daniel F. ;
Albert, Daniel A. .
ARTHRITIS CARE & RESEARCH, 2010, 62 (02) :170-180
[9]  
Kumar A, 2009, SE ASIAN J TROP MED, V40, P581
[10]   Incidence of Hyperuricemia in Patients with Acute Myocardial Infarction - A Case-Control Study [J].
Mal, Kheraj ;
Ali, Jamila Begum Jabar ;
Fatima, Kiran ;
Rizwan, Amber .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2020, 12 (01)